ScholarIQanswers from OpenAlex

Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies

PaperCitations, authors & open-access status

Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies have?

ScholarIQcitation count

Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies has 3 citations in the OpenAlex counts ScholarIQ stores.

When was Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies published?

ScholarIQyear

Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies has 2023 year in the ScholarIQ index.

What is the open-access status of Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies?

ScholarIQoa status

Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies has bronze oa status in the ScholarIQ index.

What is the DOI of Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies?

ScholarIQdoi

The DOI for Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies is on the source record.

What is the PMID of Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies?

ScholarIQpmid

The PMID for Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies is on the source record.

What is the OpenAlex record for Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies?

ScholarIQopenalex

The OpenAlex for Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial